Federal Clinical Data Model Harmonization (CDMH) Ziel: Harmonisierung mit dem Nationalen COVID-Forschungs-datensatz des BMBF/BMG & EU-Vorgaben & ISARIC WHO & LEOSS Dank #FHIR und #Snomed #LOINC ist es möglich. Nicht einfach, aber wir schaffen das 💪🏻

Haven't counted the number of completed cases yet, but today was our most successful day since we started, with 150 newly created case reports in just one day. You are awesome, folks. #COVID19 #LEOSS

To all the #DataScientists: we are very sorry for the delay, #anonymization pipeline is behind schedule. We know you are waiting and this remains among our top priorities. Publishing data is a high risk for patient #privacy and we must do this 100% on the first try. #COVID19

Remember how we reported that Monday was our day with highest documentation activity yet? Well, that was almost doubled on Tuesday. Incredible. #COVID19

Morgen 14 Uhr im hih-2025 : Premiere: Der ‚Bundeseinheitliche Forschungsdatensatz zu COVID-19‘ Konsens aller Universitätskliniken auf Basis internationaler Standards👏🏻 LEOSS HL7 Germany SNOMED International LOINC HiGHmed MIRACUM #SMITH #DIFUTURE SITiG #GECCO 🌍

Our newsletter #COVID19 is out! bit.ly/2X6pbVg Topics: interview with Thomas Illig MHHPublicHealth and Janne Vehreschild about LEOSS study, GBN webinar recordings, #DeCOI initiative and much more! Subscribe here: bit.ly/2ZcNyTI #biobank #biobanking

Unser erster #FD_Tipp ist europäisch: leoss.net/data/ LEOSS #lifesciences

We are hiring, PostDoc + PhD in translational cancer outcomes, and you'd be part of the great team that brought you #LEOSS 😏 VomLaborInDiePraxis DKFZ

Well done Robert Koch-Institut, every German plz grab a copy. Make LEOSS obsolete!

We are very proud of what the DZIF has acchieved in 2019. Read more in our Annual Report: ow.ly/WKQG50Cb2Gt #DZIF_annualreport #infectionreserach #translationalresearch

First report of the LEOSS cancer cohort is online! Check it out here: link.springer.com/article/10.100… #COVID19 #Cancer

LEOSS just included patient no. 5,000. We are humbled by the continued activity of our study centers in these difficult times. Remember, LEOSS is a community study that does not pay a dime. Our investigators sacrifice their spare time to improve our understanding of #COVIDー19.

Open data comes at a cost - hundreds of hours of analysis for the perfect anonymization algorithms. The result: unbiased results in a deidentified dataset open for public use here rdcu.be/cbX3g. Worth every minute. Thanks to ARX for a great job & tireless effort!

Stanislas Werfel's group designed the CAPS-D score for #COVID19 with LEOSS data and is particularly exciting: simple to calculate, good #prediction, and relies only on cheap and universally available clinical parameters. Check out the preprint! medrxiv.org/content/10.110…

Die Genugtuung, ja fast Schadenfreude über die Schwierigkeit, #Delta in #Australien durch #NoCovid einzudämmen, ist befremdlich. Länder, das in den letzten 1,5 Jahren umgesetzt haben, hatten kaum #COVID19 Tote, kein #LongCovid, keine Schulschließung & praktisch ein normales Leben

As a European🌍 and international🗺️ network of multidisciplinary teams collaborating on scientific research 🧪🧬🧮of COVID-19, ORCHESTRA aims to work together for a broader understanding of the disease. Interested? Please check out our collaborations site: orchestra-cohort.eu/collaborations/

Corona-Lage am 29.10.2020 (links): ⏺️ Wildtypus ⏺️ 0% Impfquote ⏺️ Inzidenz = 99 ⏺️ 1696 Intensivpatienten ⏺️ 367 Tote in 7 Tagen Corona-Lage am 29.10.2021 (rechts): ⏺️ Delta ⏺️ 69% Impfquote ⏺️ Inzidenz = 139 ⏺️ 1868 Intensivpatienten ⏺️ 585 Tote in 7 Tagen WELT

Auch wichtig- die Antigentests (3 verschiedene von Roche, Siemens und Flowflex) sind auch bei Omicron positiv und funktionieren!

Wir suchen Verstärkung in der Forschung, PostDoc, gern mit virolog. Vorerfahrung, Bewerbungen bis 02.01.22, weitere Infos hier: kgu.de/karriere

unsere ersten Daten zur Neutralisation von Omicron versus Delta sind fertig: 2x Biontech, 2x Moderna, 1xAZ/1x Biontech nach 6 Monaten 0% Neutralisation bei Omicron, auch 3x Biontech 3 Monate nach Booster nur 25% NT versus 95% bei Delta. Bis zu 37fache Reduktion Delta vs. Omicron